Imaging in rheumatoid arthritis:: Results of group discussions

被引：0

作者：

Molenaar, ETH

Boers, M

van der Heijde, DMFM

Alarcón, G

Bresnihan, B

Cardiel, M

Edmonds, J

Felson, D

Furst, DE

Kirwan, J

Lassere, M

Paulus, H

Rau, R

van Riel, PLCM

Scott, D

Simon, L

Strand, V

机构：

[1] Free Univ Amsterdam Hosp, Dept Rheumatol, NL-1007 MB Amsterdam, Netherlands

[2] Univ Hosp Maastricht, Dept Rheumatol, Maastricht, Netherlands

[3] Univ Alabama, Dept Med, Birmingham, AL 35294 USA

[4] St Vincents Hosp, Dept Rheumatol, Dublin 4, Ireland

[5] Inst Nacl Nutr Salvador Zubiran, Mexico City 14000, DF, Mexico

[6] St George Hosp, Dept Rheumatol, Sydney, NSW, Australia

[7] Boston Univ, Arthrit Ctr, Boston, MA 02215 USA

[8] Virginia Mason Res Ctr, Seattle, WA 98101 USA

[9] Univ Bristol, Rheumatol Unit, Bristol, Avon, England

[10] Univ Calif Los Angeles, Los Angeles, CA USA

[11] Evangel Fachkrankenhaus Ratingen, Ratingen, Germany

[12] Univ Nijmegen Hosp, Dept Rheumatol, Nijmegen, Netherlands

[13] Stanford Univ, Div Immunol, Stanford, CA 94305 USA

[14] Free Univ Amsterdam Hosp, Dept Clin Epidemiol, NL-1007 MB Amsterdam, Netherlands

来源：

JOURNAL OF RHEUMATOLOGY | 1999年 / 26卷 / 03期

关键词：

rheumatoid arthritis; radiographs; scoring methods; Larsen method; Sharp method; magnetic resonance imaging;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

None of the current scoring methods for radiological damage in rheumatoid arthritis (RA) is ideal. The objective for RA imaging at OMERACT IV was to start discussion about the problems and applicability of the current scoring methods for radiological damage and to start discussion on the challenge of new imaging techniques. The RA imaging module comprised preconference reading material, plenary sessions, small group discussions, and a plenary report of the group sessions, combined with interactive voting. The OMERACT filter guided the discussions. Priorities for further research in imaging studies were: (1) pathologies Versus features on radiographs; (2) relation with longterm outcome; and (3) definition of minimum clinically important difference.

引用

页码：749 / 751

页数：3

共 9 条

[1] STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
BLAND, JM
ALTMAN, DG
[J]. LANCET, 1986, 1 (8476) : 307 - 310
[2] Boers M, 1998, J RHEUMATOL, V25, P198
[3] Bresnihan B, 1999, J RHEUMATOL, V26, P717
[4] Delbecq AL., 1975, Group Techniques for Program Planning: A Guide to Nominal Group and Delphi Techniques
[5] FRIED BJ, 1993, J RHEUMATOL, V20, P548
[6] Kirwan JR, 1999, J RHEUMATOL, V26, P720
[7] Lassere M, 1999, J RHEUMATOL, V26, P731
[8] Molenaar ETH, 1999, J RHEUMATOL, V26, P746
[9] van der Heijde D, 1999, J RHEUMATOL, V26, P726

← 1 →